​
​

Oncternal Therapeutics Ownership | Who Owns Oncternal Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Oncternal Therapeutics Ownership Summary

Oncternal Therapeutics is owned by 14.22% institutional investors, and 85.78% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.65% of its assets in Oncternal Therapeutics shares.

ONCT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOncternal Therapeutics14.22%-85.78%
SectorHealthcare Stocks 46.62%8.13%45.25%
IndustryBiotech Stocks 44.91%7.98%47.11%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202337-27.45%8,387,388-10.11%145.63%10-37.50%7-22.22%
Sep 30, 202351-3.77%9,330,559-1.39%156.08%16-9-25.00%
Jun 30, 202353-1.85%9,462,1401.35%166.35%166.67%12-
Mar 31, 202354-10.00%9,336,2645.38%155.62%15-40.00%12-14.29%
Dec 31, 2022607.14%8,859,703-5.75%165.60%2566.67%14-26.32%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv107.99K3.65%-
Vanguard Institutional Extnd Mkt Idx Tr31.06K1.05%-
Fidelity Extended Market Index15.01K0.51%-61.00
BlackRock Extended Equity Market K5.61K0.19%-2.00
Fidelity Total Market Index4.03K0.14%-
Fidelity Series Total Market Index3.30K0.11%-
DFA US Targeted Value I2.94K0.10%2.52K
NT Ext Equity Mkt Idx Fd - NL2.01K0.07%-
Northern Trust Extended Eq Market Idx1.95K0.07%-
NT Ext Equity Mkt Idx Fd - L1.95K0.07%-

Recent Insider Transactions

DateNameRoleActivityValue
Apr 08, 2024Wills Robert James-Buy$27.65K
Mar 28, 2024Wills Robert James-Buy$58.60K
Feb 23, 2024HALE DAVID F-Buy$2.40K
Feb 23, 2024HALE DAVID F-Buy$6.45K
Feb 23, 2024Wills Robert James-Sell$8.86K

Insider Transactions Trends

DateBuySell
2024 Q21-
2024 Q131
2023 Q4--
2023 Q3--
2023 Q211-

ONCT Ownership FAQ

Who Owns Oncternal Therapeutics?

Oncternal Therapeutics shareholders are primarily institutional investors at 14.22%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Oncternal Therapeutics's industry, Biotech Stocks , is 44.91%, which Oncternal Therapeutics falls below.

Does Blackrock own Oncternal Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Oncternal Therapeutics.

Who is the top mutual fund holder of Oncternal Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Oncternal Therapeutics shares, with 3.65% of its total shares outstanding invested in 107.99K Oncternal Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools